BioPartnering Conference Committees

BioNJ Members collaborate in planning multiple conference components that culminate in a single day of company presentations, partnering meetings, plenary sessions and exhibits that convenes over 450 life sciences industry thought leaders, investors, business development professionals and academic collaborators. Various committees assist with company and investor recruitment, presentation coaching, speaker identification and program development.

Committee Members:

Adastra Pharmaceuticals, Inc. – Scott Megaffin, CEO
Ashton Tweed, LTD – Jordan Warshafsky, MBA, Partner
CohnReznick LLP – Ravi Raghunathan, CPA, Partner, Life Sciences Industry Leader
Coriell Institute for Medical Research – Ellen Kelly, PhD, Director, Business Development
DLA Piper – Emilio Ragosa, JD, Partner
DLA Piper – Rene Veloso, Client Development Executive
EisnerAmper LLP – Michael Hadjiloucas, MS, CPA, Partner-in-Charge, Corporate Tax Group
EisnerAmper LLP – John Pennett, CPA, Partner-in-Charge, National Life Sciences & Technology Group
EY – Tony Torrington, CPA, Partner
EY – Arda Ural, MSc, MBA, Ph.D., Partner, Life Sciences, Transaction Advisory Services
Hackensack Meridian Health – Sandra Elliott, MBA, Vice President, Life Sciences and Innovation
Hart & Chin Associates, LLC – Juliet Chin-Hart, MBA, Principal
J.P. Morgan – Kathleen Addison, Executive Director, Life Sciences
J.P. Morgan – Dana D’Amelio, Associate
J.P. Morgan – Kenneth Freelund, MBA, Executive Director
J.P. Morgan – Frank Frigo Jr., Senior Marketing Associate
J.P. Morgan – Andy Harlan, CFP, Executive Director, Banker
J.P. Morgan – Rohit Mehrotra, Vice President
Johnson & Johnson Innovation – Jayen Palekar, MBA, Therapeutic Area Leader, Oncology
Johnson & Johnson Innovation – Caroline Pavis, Business Unit Communications Leader, Oncology & Actelion
Johnson & Johnson Innovation – Sabina Perchik, M.S., Director, Transactions – Oncology Business Development
LeaderStrong – Jack Levitt, MBA, EMTM, Co-Founder & Principal
McCarter & English, LLP – Beverly W. Lubit, Ph.D., Partner
NDA Group – Nancy Maira, MBA, Business Development Associate, US
Novartis – Dawn Bell, Pharm D., Global Development Head, Strategic Partnerships Team
Princeton University – Dean Edelman, JD, Life Sciences Lead, Office of Corporate Engagement and Foundation Relations
Rutgers, The State University of New Jersey – Vincent Smeraglia, JD, Executive Director, Office of Research Commercialization

Please contact Samantha Bamberger at if interested in participation.